Valion Bio, Inc (VBIO) insider trading
Every open-market stock purchase and sale by Valion Bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Joseph E. LoConti (10% owner), $200, 5 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.96 on Oct 22, 2026.
Recent VBIO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 22, 2026 | Dean Zikria (CEO) | Bought (not open market) | — |
| Sep 18, 2026 | Lisa G Wolf (CFO) | Sold (not open market) | $4 |
| Sep 18, 2026 | Lisa G Wolf (CFO) | Bought (not open market) | — |
| Sep 18, 2026 | Lisa G Wolf (CFO) | Bought (not open market) | — |
| Jun 18, 2026 | Lisa G Wolf (CFO) | Bought (not open market) | — |
| May 18, 2026 | Michael K Handley (CEO) | Bought (not open market) | — |
| May 1, 2026 | Melinda Lackey (VP) | Bought (not open market) | — |
Who's trading VBIO
- Dean Zikria, CEO: other filings, last Sep 22, 2026
- Lisa G Wolf, CFO: other filings, last Sep 18, 2026
- Michael K Handley, CEO: other filings, last May 18, 2026
- Melinda Lackey, VP: other filings, last May 1, 2026
Get free alerts when an insider at Valion Bio, Inc files a new trade →